SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-17-003016
Filing Date
2017-04-28
Accepted
2017-04-28 06:01:29
Documents
13
Period of Report
2017-06-28
Effectiveness Date
2017-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2231809zdef14a.htm DEF 14A 1001659
2 G202915.JPG g202915.jpg GRAPHIC 17152
3 G1012795.JPG g1012795.jpg GRAPHIC 6628
4 G880514.JPG g880514.jpg GRAPHIC 18801
5 G331047.JPG g331047.jpg GRAPHIC 17950
6 G957789.JPG g957789.jpg GRAPHIC 16759
7 G333825.JPG g333825.jpg GRAPHIC 5367
8 G413593.JPG g413593.jpg GRAPHIC 68071
9 G890231.JPG g890231.jpg GRAPHIC 200350
10 G23632BII001.GIF g23632bii001.gif GRAPHIC 138964
11 G23632BII002.GIF g23632bii002.gif GRAPHIC 177991
12 G23632BKI001.GIF g23632bki001.gif GRAPHIC 154563
13 G23632BKI002.GIF g23632bki002.gif GRAPHIC 198853
  Complete submission text file 0001047469-17-003016.txt   2410891
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-26301 | Film No.: 17791508
SIC: 2834 Pharmaceutical Preparations